BRIEF-Cardiff Oncology - Nms Informs Cardiff Oncology Of Agreement Termination On May 27, 2026

Cardiff Oncology, Inc.

Cardiff Oncology, Inc.

CRDF

0.00

May 29 (Reuters) - Cardiff Oncology Inc CRDF.O:

  • CARDIFF ONCOLOGY - NMS INFORMS CARDIFF ONCOLOGY OF AGREEMENT TERMINATION ON MAY 27, 2026 - SEC FILING

  • CARDIFF ONCOLOGY - NMS ALLEGES CARDIFF ONCOLOGY BREACHED AGREEMENT OVER CARDIFF PATENTS INVENTORSHIP - SEC FILING

  • CARDIFF ONCOLOGY - NMS ALLEGES FAILURE BY CARDIFF ONCOLOGY TO USE COMMERCIALLY REASONABLE EFFORTS FOR ONVANSERTIB - SEC FILING

  • CARDIFF ONCOLOGY - STATES NMS TERMINATION NOTICE IS INEFFECTIVE AND WILL CONTINUE UNDER AGREEMENT - SEC FILING

Further company coverage: CRDF.O


This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.